Mark Ibberson

Nov 18, 2024 | nature.com | Abigail C. Lay |Frédéric Burdet |Florence Mehl |Dmytro Kryvokhyzha |Abrar Ahmad |Matthew Sinton | +9 more

AbstractDiabetic kidney disease (DKD) is the leading cause of end stage kidney failure worldwide, of which cellular insulin resistance is a major driver. Here, we study key human kidney cell types implicated in DKD (podocytes, glomerular endothelial, mesangial and proximal tubular cells) in insulin sensitive and resistant conditions, and perform simultaneous transcriptomics and proteomics for integrated analysis.

Jul 1, 2024 | nature.com | Anna L Gloyn |Mark Ibberson |Alvin C. Powers |Patrik Rorsman

Correction to: Nature Metabolism https://doi.org/10.1038/s42255-022-00607-8, published online 11 August 2022In the version of this article initially published, the name of the Human Pancreas Analysis Program was written incorrectly and has now been amended in the HTML and PDF versions of the article. About this articleGloyn, A.L., Ibberson, M., Marchetti, P. et al. Author Correction: Every islet matters: improving the impact of human islet research. Nat Metab (2024).

May 3, 2023 | nature.com | Roderick C. Slieker |Eleni Georgiadou |Giuseppe Giordano |Emma Ahlqvist |Ashfaq Ansari Ali |Karina Banasik | +22 more

Discovery cohorts Summary statistics of lipidomic, proteomic and metabolomic data is available from a Shiny dashboard available from: https://rhapdata-app.vital-it.ch. The generated metabolomic, lipidomic and proteomic data in DCS, GoDARTS and ANDIS are considered sensitive patient data and can therefore not be publicly available in compliance with the European privacy regulations governed by GDPR and according to limitations included in the informed consents signed by the study participants.